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 Based on the above blot probed for P44-MAPK, similar density bands can be 
observed between wild type and mutant. This indicates that P44-MAPK signaling seems 
to be conserved. On the other hand, there are several differences between wild type and 
mutant in downstream PKA substrates. These differences are noted by stars on the right 
side of Figure 12. These differences indicate that there may be slight differences in 


























































MATERIALS PROVIDED		 	 	 Quantitya	 	
Materials provided	 Catalog #204121	 Catalog #204122	 Catalog #204123	
	 	 	 	
SatisFection Transfection Reagent	 0.3 ml	 0.75 ml	 2 × 0.75 ml	
	 	 	 		
a The reagent has been optimized for 625–1250 transfections per 0.75 ml transfection reagent using 24-well 
tissue culture dishes. 	
STORAGE CONDITIONS		
SatisFection Transfection Reagent: 4°C		
ADDITIONAL MATERIALS REQUIRED		
Media for preparing transfection mixture (Opti-MEM, DMEM, RPMI or other cell culture media		
without serum and antibiotics)		
Media for cell growth (Opti-MEM, DMEM, RPMI, or other cell culture media, including serum, 
growth factors, and antibiotics if appropriate)			
Revision B	 © Agilent Technologies, Inc. 2010.												
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INTRODUCTION		
Gene transfection into eukaryotic cells is a fundamental tool for analysis of 
gene function and for production of recombinant gene products. 
SatisFection Transfection Reagent gives optimal efficiencies and protein 
expression levels in common cell lines, while significantly improving 
efficiencies in many hard-to-transfect and primary cells. Maximum gene 
expression and protein production is observed 36–72 hours post-
transfection.		
The SatisFection reagent is a novel cationic polymer suitable for both 
transient and stable transfections in the presence or absence of serum. This 
polymer functions by binding and condensing DNA into a polyplex that 
enters the cell via endocytosis. Properties of the polyplex facilitate both 
endosomal rupture and protection of the bound DNA from lysosomal 
degradation. Continued exposure to cellular pH ultimately reduces the 
polymer into a non-toxic monomer. The monomer is then easily excreted 
from the cellular compartment, resulting in lowest the levels of cytotoxicity 
and increased cell viability. As a result, the SatisFection reagent is ideal for 
experiments that require large, healthy populations of positively transfected 
cells for downstream applications, e.g., signal transduction pathway 
analysis.		
PREPROTOCOL CONSIDERATIONS		
The protocol provided below will allow effective transfections for most cell 
types, however, optimal transfection conditions may vary. The following 
parameters should be established for each cell line and plasmid used.		
DNA Quality and Concentration		
The use of highly purified DNA is critical for successful transfection. 
Suitable quality DNA is obtained using StrataPrep plasmid miniprep kit, or 
by cesium chloride purification. The optimal concentration for transfection 
generally falls within the range of 0.4–1.0 µg DNA per well of a 24-well 
plate, with 0.6 µg as the recommended starting point for optimization.		
Cell Density		
While we recommend a cell density of 60–80% confluence after 18–24 
hours of incubation at the time of transfection for most cell types, the 
optimal cell density should be determined specifically for each cell type.		
Reagent to DNA Ratio		
The optimal reagent to DNA ratio should allow the highest transfection 
efficiencies with the lowest level of toxicity. This is usually achieved within 
the range of 1–2 µl reagent per µg DNA, with 1.5 µl reagent per µg DNA 
the recommended starting point for optimization.		
Transfection Incubation Time		
The optimal time that the transfection reagent is in contact with the cells 
should be determined by testing a range of incubation times from 36–72 
hours.		
2	 SatisFection Transfection Reagent	
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SATISFECTION TRANSFECTION REAGENT VOLUME GUIDELINES		
The following procedure for the generation of transfectants uses a 24-well 
tissue culture plate. The optimal ratio of SatisFection transfection reagent to 
DNA must be determined for each plasmid and cell line, however 1.5 µ1 
reagent per 1 µg DNA is the recommended starting point for optimization. 
Reagent volumes for cells not cultured in 24-well tissue culture plates are 
given in Table I. When preparing the transfection mixture, the volume of the 
transfection mixture may be scaled up by increasing the components 
proportionally to accommodate several transfections.		
TABLE I		
SatisFection Transfection Reagent use for Various Cell Culture Dish Formats a			 	 	 DNA solution per well	 Transfection reagent per well	 	 	
	 	 	 	 	 	 	 	 		 	 	 	 	 Volume of	 	 	 		 	 	 	 Final volume	 transfection	 Final volume of	 	 		 	 	 	 of DNA	 reagent stock	 transfection	 Total	 	
Tissue	 	 Recommended	 	 solution	 solution (µl)	 reagent	 volume of	
culture	 Diameter	 number of	 Amount	 diluted with	 [1.5:1 ratio	 solution diluted	 transfection	
dish	 of the well	 adherent cells	 of DNA	 serum-free	 (µl reagent:	 with serum-free	 mixture plus	
format	 (mm)	 (×105)	 (µg)	 medium (µl)	 µg DNA)]	 medium (µl)	 medium (µl)	
96-well	 6.4	 0.04–0.1	 0.15	 7.5	 0.225	 7.5	 15	µl	
	 	 	 	 	 	 	 	 	
48-well	 10	 0.1–0.3	 0.3	 15	 0.45	 15	 30	µl	
	 	 	 	 	 	 	 	 	
24-well	 15	 0.27–0.67	 0.6	 30	 0.9	 30	 60	µl	
	 	 	 	 	 	 	 	 	
12-well	 22	 0.6–1.5	 1	 50	 1.5	 50	 100	µl	
	 	 	 	 	 	 	 	 	
6-well	 35	 1.5–3.7	 2	 100	 3	 100	 200	µl	
	 	 	 	 	 	 	 	 	
35-mm	 35	 1.5–3.7	 2	 100	 3	 100	 200	µl	
	 	 	 	 	 	 	 	 	
60-mm	 60	 4.0–11.0	 6	 300	 9	 300	 600	µl	
	 	 	 	 	 	 	 	 	
100-mm	 100	 12.0–31.0	 16	 800	 24	 800	 1600	µl	
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SatisFection Transfection Reagent		
Catalog #204121, 204122, and 204123		
QUICK-REFERENCE PROTOCOL–ADHERENT CELLS		
Seed cells to 2.7–6.7 × 104 cells per well of a 24-well plate and incubate 18–24 
hours so that cells are at 60–80% confluency at time of transfection		
Prepare transfection mixture		
♦ Pipet 30 µl antibiotic-free, serum-free medium (room temperature) into 
microcentrifuge tube. Pipet reagent (0.9 µl) into medium, do not touch plastic. 
♦ Pipet 30 µl antibiotic-free, serum-free medium (room temperature) into separate 
microcentrifuge tube. Add DNA (0.6 µg) to medium. 
♦ Add the diluted transfection reagent dropwise to the diluted DNA while gently 
vortexing or mixing with the pipet tip.  
♦ Incubate transfection mixture 15 minutes at room temperature. 	
Add the transfection mixture to the cells		
♦ Add transfection mixture dropwise and incubate for 36–72 hours under standard 
growth conditions. 	
Perform stable transfection (optional)		
♦ 36–72 hours after the transfection (above), split cells (1:5 suggested).  
♦ After 24 hours, apply selection antibiotics.  
♦ Continue selection, replacing medium every 4–7 days until colonies form. 
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Appendix	C:	Protein	Extraction	and	Western	Blot		
Protein Extraction Protocol 
1) Do all steps on ice or at 4o. 
 
2) Rinse cells with 1X PBS (1 ml, ice cold) 
 
3) Add 0.5 ml lysis buffer/well 
 
4) Incubate on ice for 20 min. 
 
5) Scrape into microfuge tube 
 
6) Transfer extract to Dounce homogenizer and homogenize with 10 strokes of Dounce 
homogenizer (tight pestle) 
 
7) Transfer extract back to microfuge tube 
 
8) Spin in microfuge in cold room for 10 min at max speed  
 
9) Transfer supernatant to new tube.  Save pellet. 
 
 
Igepal-DOC lysis buffer    
1% Igepal     
0.4% deoxycholate 
10mM Tris pH7. 
6.6mM EDTA 
 
-add 1X protease inhibitor cocktail before using lysis buffer 
 













BCA protein assay (Pierce Biotech, cat. #23225) 
Mini-PROTEAN II gel apparatus (Biorad) 
Costar gel-loading tips (Krackler Scientific, cat. #MN520R-LRS) 
Prestained SDS-Page broadrange molecular weight standard (NEB, cat. #P7708S) 
Trans-blot Semi-Dry Transfer cell (Biorad)        
Immobilon-P membrane (Millipore, cat. #IPV00010) 
heat-sealable bags (Kapak, cat. #TRS-95250) 
Kodak Biomax light autoradiagraphy film, 13 x 18 cm (Perkin Elmer Life Sciences, cat. #868-
9358)  









Acrylamide solution (30% acrylamide/0.8% bis-acrylamide) 
-dissolve 30g acrylamide (FW=71.08), 0.8g bis-acrylamide (FW=154.17) in a total 
volume of 100ml water. Filter through 0.2um filter. 
 
4X Running Gel Buffer (1.5M Tris, pH 8.8) 
-dissolve 36.3g Tris Base (FW=121.1) in 150ml water. Adjust to pH 8.8. Add water to 
total volume of 200ml. Filter through 0.2um filter.     
 
4X Stacking Gel Buffer (0.5M Tris, pH 6.8) 
-dissolve 12.1g Tris Base (FW=121.1) in 150ml water. Adjust to pH 6.8. Add water to 
total volume of 200ml. Filter through 0.2um filter. 
 
10% SDS 
 -dissolve 10g SDS (FW=288.38) in a total volume of 100ml water. 
 
10% Ammonium Persulfate 
 -dissolve 1.0g APS (FW=228.2) in a total volume of 10ml water. Store at -20˚C in 50-
100ul aliquots. 
 
1M Tris, pH 6.8 
-dissolve 12.1g Tris Base (FW=121.1) in 80ml water. Adjust to pH 6.8. Add water to 
total volume of 100ml. Filter through 0.2um filter. 
 
 
6X SDS Sample Buffer (0.375M Tris pH 6.8, 12% SDS, 60% glycerol, 0.6M DTT, 0.06% 
bromophenol blue) 
	 33	
-combine 3.75ml 1M Tris-Cl, pH 6.8, 6ml glycerol, 1.2g SDS (FW=288.38), 0.93g DTT 
(FW=154.2), 6mg bromophenol blue. Add water to total volume of 10ml. Store at -20˚C in 
0.5ml aliquots. 
2X SDS Sample Buffer (0.125M Tris pH 6.8, 4% SDS, 20% glycerol, 0.2M DTT, 0.02% 
bromophenol blue) 
-combine 2.5ml 4X Tris pH 6.8 (stacking gel buffer), 2ml glycerol, 4ml 10% SDS 
(FW=288.38), 0.31g DTT (FW=154.2), 2mg bromophenol blue. Add water to total volume 
of 10ml. Store at -20˚C in 0.5ml aliquots. 
1X SDS Sample Buffer (0.0625M Tris pH 6.8, 2% SDS, 10% glycerol, 0.1M DTT, 0.01% 
bromophenol blue) 
 
5X Electrophoresis Buffer (0.125M Tris, 0.96M glycine, 0.5% SDS) 
-dissolve 30.3g Tris Base (FW=121.1), 144.1g glycine (FW=75.07), and 10g SDS 
(FW=288.38) in a total volume of 2L water.                                                   
1X Electrophoresis Buffer (0.025M Tris, 0.192M glycine, 0.1% SDS) 
 -add 200ml 5X electrophoresis buffer to 800ml water. 
 
Western Blot Buffers 
Transfer Buffer (0.048M Tris, 0.039M glycine, 20% methanol, 0.00375% SDS)     
-dissolve 11.64g Tris Base (FW=121.1), 5.86g glycine (FW=75.07) in ~1500ml water. 
Add 0.750ml 10% SDS (FW=288.38). Add 400ml methanol. Add water to total volume 
of 2L. No pH adjustment necessary. 
 
10X TBST Wash Buffer (0.1M Tris HCl, 1.5M NaCl, 0.5% Tween-20)         
-dissolve 31.52g Tris HCl (FW=157.6), 175.32g NaCl (FW=58.44) in ~1900ml water. 
Add 10ml       Tween-20. Adjust to pH 7.2.  Add water to total volume of 2L.   
  
 
1X TBST Wash Buffer (0.01M Tris HCl, 0.15M NaCl, 0.05% Tween-20) 
 -add 100ml 10X TBST to 900ml water. 
 
5% milk Blocking Buffer  
-Dissolve 5g milk in a total volume of 100ml 1X TBST.   
 
Method    
1. Determine cell number or protein concentration to be loaded onto gels and what volume to 
load per well.  Note max volumes for different comb configurations.  
 
2. Usually add sample to Tris or PBS and then add sample buffer (2 ul sample + 18 ul PBS + 3.3 
ul 6X sample buffer).  
 
3. Sonicate cells briefly on ice to homogenize.  Purified protein samples do not need to be 
sonicated.  
 
4. Preparing resolving and stacking gels (for BioRad Mini-PROTEAN II): Make sure glass plates 
are clean.  Use Sparkleen or Alconox powder to clean plates.  Rinse with distilled water and then 
	 34	
95% EtOH.  Wipe dry with KimWipes.  Select a comb and spacer (ex. 0.75 mm).  Place spacers 
in between the inner and outer glass plates.  Make sure that the spacers are flush with the plates. 
Insert plates into the clamping assembly and tighten screws.  Vacuum grease can be used on the 
casting stand gaskets to prevent buffer leakage.  Snap assembly into the casting stand.  Prepare 
resolving gel.  Pour gel and overlay with 1X Electrophoresis Buffer or isopropanol (use 3.5ml 
resolving gel when using 0.75mm spacers and 7.0ml gel for 1.5mm spacers, this will produce a 
gel approx. 3.25" x 2"). Look for a division between the overlay and resolving gel, this means 
the gel is polymerized.  Pour off overlay, use thin strips of Whatman paper to remove any excess.  
Pour stacking gel and insert comb.  Remove comb when stacking gel is polymerized.  Use a 
syringe and a 12 gauge needle to wash stacking gel wells. Snap clamp assembly into electrode 
assembly.  Vacuum grease can be used on electrode assembly gaskets to prevent buffer leakage. 
 
5. Boil samples 5 minutes at 100°C, and then spin tubes at 13,000rpm for ~1min. in RT micro 
centrifuge. Load samples using Costar Gel-Loading Tips.     
 
6. Place electrode assembly with loaded samples into an electrophoresis chamber. Fill the 
electrode assembly carefully with 1X Electrophoresis Buffer. Fill the electrophoresis chamber 
with 1X Electrophoresis Buffer.  Run gels at 100V for stacking gel, 100-150V for resolving gel 
(can increase to 200V for resolving gel if running on ice). 
   
7. To transfer mini- gels to Immobilon-P membrane using the BioRad Semi-Dry Transfer Cell:  
Remove gels from glass plates. Cut stacking gel away and discard. Incubate gels in Transfer 
Buffer for 20 - 40 min. Cut out 6 pieces of Whatman paper and 1 piece of Immobilon-P 
membrane for each gel that is being transferred. They should be 3.25" x 2". Incubate Immobilon-
P membrane in Methanol for ~10 - 20 seconds. Wet Immobilon-P membrane and Whatman 
paper in Transfer Buffer for 5 - 10 minutes before assembling the gel sandwich according to the 
BioRad Reference Guide. Transfer 1 mini-gel for 15 min. at 15 V, max current.  Transfer 2 mini-
gels for 30 min at 15 V, max current. Make sure that pre-stained MW markers transfer to 
Immobilon-P membrane.   
 
8. Western Blot:   
-Block membrane in 20ml blocking buffer overnight at 4°C or 1h at room temperature on 
rocker in a seal-a-meal bag. 
-Dilute Ab in blocking buffer (1:1000 for serum or 5ug / 10ml for purified Ab). Incubate 
blots with Ab for 1h at rom temperature or overnight at 4°C on rocker in a seal-a-meal 
bag. 
 -Wash blots with 50ml 1X TBST on orbital shaker 3 times, 5 minutes each. 
-Dilute HRP conjugated Ab 1:10,000. Incubate blots with secondary Ab for 1h at room 
temperature or overnight at 4°C on rocker in a seal-a-meal bag.                               
-Wash blots with 50ml 1X TBST on orbital shaker 3 times, 5 minutes each.     
-Add 5ml chemiluminescent substrate to each blot, incubate for 5 minutes. Place blots in 
between transparency film. Push out air bubbles. Develop Western blot. Do a 1 minute 
exposure to check signal intensity. Continue with longer or shorter exposures as needed.   
               (Max. exposure length = 10 min.  Min exposure length = 60 sec.)  






















Running Gel: 7.5, 10, or 15% acrylamide, 0.375M Tris-Cl pH 8.8, 0.1% SDS, 0.33% APS, 
0.66% TEMED 
 




















 7.5% gel (15ml) 10% gel (15ml) 
15% gel 
(15ml) 





3.75ml 5ml 7.5ml 
4X Running 
Buffer 3.75ml 3.75ml 3.75ml 
10% SDS 150ul 150ul 150ul 
10% APS 150ul 150ul 150ul 
TEMED 20ul 20ul 20ul 
 4% gel (10ml) 
Water 6.1ml 
30% acrylamide/ 
0.8% bis-acrylamide 1.3ml 
4X Stacking Buffer 2.5ml 
10% SDS 100ul 
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